SCHEMBL2535110

SCHEMBL2535110

CCOC(=O)c1ccc2c(c1)CC(C)(C)C(c1cccc([N+](=O)[O-])c1)N2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1C Q13936 14/20 0.54
CACNA1F O60840 13/20 0.54
CACNA1D Q01668 13/20 0.54
CACNA1S Q13698 13/20 0.54
ADORA3 P0DMS8 1/20 0.54
ALDH1A1 P00352 2/20 0.52
HIF1A Q16665 3/20 0.51
MEN1 O00255 2/20 0.51
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
KMT2A Q03164 2/20 0.51
MAPT P10636 2/20 0.51
LMNA P02545 1/20 0.51
POLB P06746 1/20 0.51
MAPK1 P28482 1/20 0.51
GPR55 Q9Y2T6 1/20 0.51
CYP2D6 P10635 1/20 0.51
TSHR P16473 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2532907 0.86 AR (0.44) ADORA3ALDH1A1HIF1AMEN1CYP1A2
SCHEMBL2530135 0.86 NR4A1 (0.53) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL2531858 0.86 AR (0.52) ADORA3ALDH1A1MEN1KMT2AMAPT
SCHEMBL2535778 0.85 MAPT (0.44) ALDH1A1MEN1CYP1A2CYP2C9CYP2C19
SCHEMBL2535682 0.85 AR (0.43) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL2536543 0.84 AR (0.42) ALDH1A1MEN1CYP1A2CYP2C9CYP2C19
SCHEMBL2538431 0.84 AR (0.42) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL2532748 0.82 AR (0.43) ALDH1A1MEN1CYP1A2KMT2AMAPT
SCHEMBL2534177 0.81 AR (0.41) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL2531219 0.81 EPHX2 (0.42) CACNA1DCYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 CACNA1C 616/4885CACNA1F 396/4885CACNA1D 278/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 CACNA1C 616/4885CACNA1F 396/4885CACNA1D 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.